UCP1 and metabolic syndrome: Oral MES supplementation improved diet-induced obesity and metabolic syndrome partially by elevating signals associated with lipid catabolism, including lipolysis, mitochondrial biogenesis, and the number of UCP1-positive cells in adipose tissues14.